Skip to Main Content
Table 2

Stem cell, promoter, and transcriptional features of the different DNA methylation gene groups

umL/umC, %meL/meC, %meL/umC, %dmeL/meC, %
PcG enrichment in embryonic stem cells 16.3 6.8 58.5 33.3 
Promoter class according to CpG content     
    LCP 17.3 56.6 3.4 13.6 
    ICP 15.1 16.9 10.7 13.6 
    HCP 67.6 26.5 85.7 72.7 
Gene expression*     
    Mature aggressive B-cell lymphomas 51.8 62.8 74.9 (**) 67.9 (**) 
    Normal hematopoietic tissues 61.4 73.2 88.3 (**) 87.4 (**) 
    Other normal tissues 74.1 77.1 74.1 (ns) 75.6 (ns) 
umL/umC, %meL/meC, %meL/umC, %dmeL/meC, %
PcG enrichment in embryonic stem cells 16.3 6.8 58.5 33.3 
Promoter class according to CpG content     
    LCP 17.3 56.6 3.4 13.6 
    ICP 15.1 16.9 10.7 13.6 
    HCP 67.6 26.5 85.7 72.7 
Gene expression*     
    Mature aggressive B-cell lymphomas 51.8 62.8 74.9 (**) 67.9 (**) 
    Normal hematopoietic tissues 61.4 73.2 88.3 (**) 87.4 (**) 
    Other normal tissues 74.1 77.1 74.1 (ns) 75.6 (ns) 

PcG indicates polycomb group; LCP, low CpG promoter; ICP, intermediate CpG promoter; HCP, high CpG promoter; umL/umC, unmethylated in lymphomas and controls; meL/meC, methylated in lymphomas and controls; meL/umC, methylated in all lymphomas but not in controls; dmeL/umC, differentially methylated in lymphoma subtypes; and ns, not significant.

*

Global expression of genes from the different methylation groups is shown as the percentage of absent detection calls. The values shown represent the mean of the different series displayed in Figures 3 and S11 (also shown in Table S5).

Results of a Fisher exact test compared with the umL/umC group.

**

Highly significant.

Close Modal

or Create an Account

Close Modal
Close Modal